Prostate and bladder cancer
Prostate cancer is one of the main health problems facing men. It is estimated that 3 out of 10 men over the age of 50 will develop prostate cancer during their lifetime. The most effective weapons to combat it are early detection through specific tests and multidisciplinary treatment at a centre of recognised excellence.
Centro Médico Teknon has internationally renowned specialists who will help you prevent, diagnose and choose the most appropriate treatment in each case. These professionals will advise you and place special emphasis on resolving the major concerns arising from the disease:
- Removing the tumour and cancer cells
- Preserving maximum sexual potency
- Maintaining urinary continence
Everything is done using the least invasive treatments that are offering the best results, as confirmed by medical studies:
- Laparoscopic surgery
- Da Vinci robot-assisted laparoscopic surgery
- Next-generation radiotherapy: True-Beam STX with the Calypso system
Comprehensive solutions
In the event of a positive diagnosis, you can rest assured that at Centro Médico Teknon you will receive the most appropriate treatment for your case.
- Radical prostatectomy with laparoscopy. The prostate gland and seminal vesicles are removed through small incisions using a minimally invasive technique, which minimises scarring, post-operative pain and hospital stay, and promotes faster recovery than traditional open surgery. This technique requires a high level of experience and expertise on the part of the specialist urologist performing it in order to achieve optimal results.
- Da Vinci robot-assisted radical prostatectomy. With its superior manoeuvrability, enhanced visual field and tremor-filtration, the Da Vinci robot ensures maximal precision in surgery, delivering all the advantages of minimally invasive surgery without the difficulties of conventional laparoscopic surgery. Research indicates that patients undergoing prostatectomy via the Da Vinci system experience faster restoration of urinary continence and sexual function, exhibit fewer positive margins, and face reduced risks compared to those having traditional open surgery or laparoscopy.
• What is the incidence of bladder cancer?
Bladder cancer is the second most common tumour of the genitourinary system after prostate cancer. Its peak incidence occurs around the seventh decade of life.
What types of tumours exist and how are they treated?
Most bladder tumours (75%) are superficial tumours. These tumours are mainly treated by transurethral resection (through the urethra using a cystoscope). Depending on the depth and grade, treatment with local chemotherapy or immunotherapy should be carried out.
The other 25% are invasive tumours. These tumours require more aggressive treatment consisting of a cystectomy (removal of the bladder). In certain circumstances, they will require treatment with intravenous chemotherapy and/or radiotherapy.